Commons Capital’s Idexx Laboratories IDXX Stock Holding History

Commons Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-838	Closed	-$458K	–	132
2022 Q1	$458K	Buy	+838	New	+$441K	0.49%	49

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Commons Capital's IDXX Position: Q2 2022 in Review

Commons Capital sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 838 shares — an estimated $458K sold.

Commons Capital first reported a position in IDXX in Q1 2022 and held it in 1 quarter. The position peaked at $458K in Q1 2022. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Commons Capital reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Commons Capital sold 838 Idexx Laboratories shares in Q2 2022, an estimated $458K.
Commons Capital first reported a position in Idexx Laboratories in Q1 2022 and held it in 1 quarter.
Commons Capital's Idexx Laboratories position peaked at $458K in Q1 2022.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Commons Capital's 13F filing for Q2 2022, filed 9 Aug 2022.